KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aurinia Pharmaceuticals (AUPH) Interest Coverage Ratio (2023 - 2025)

Aurinia Pharmaceuticals' Interest Coverage Ratio history spans 3 years, with the latest figure at 31.75 for Q4 2025.

  • For Q4 2025, Interest Coverage Ratio rose 2279.86% year-over-year to 31.75; the TTM value through Dec 2025 reached 24.23, up 2599.47%, while the annual FY2025 figure was 24.23, 2599.47% up from the prior year.
  • Interest Coverage Ratio reached 31.75 in Q4 2025 per AUPH's latest filing, up from 27.07 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 31.75 in Q4 2025 to a low of 248.77 in Q2 2023.
  • Average Interest Coverage Ratio over 3 years is 17.19, with a median of 1.26 recorded in 2024.
  • Peak YoY movement for Interest Coverage Ratio: surged 93.57% in 2024, then soared 2279.86% in 2025.
  • A 3-year view of Interest Coverage Ratio shows it stood at 22.65 in 2023, then soared by 93.57% to 1.46 in 2024, then surged by 2279.86% to 31.75 in 2025.
  • Per Business Quant, the three most recent readings for AUPH's Interest Coverage Ratio are 31.75 (Q4 2025), 27.07 (Q3 2025), and 17.98 (Q2 2025).